| Pharmaceutical Information |
| Drug Name |
Lercanidipine |
| Drug ID |
BADD_D01255 |
| Description |
Lercanidipine is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip. |
| Indications and Usage |
For the treatment of Hypertension, management of angina pectoris and Raynaud's syndrome |
| Marketing Status |
Not Available |
| ATC Code |
C08CA13 |
| DrugBank ID |
DB00528
|
| KEGG ID |
D08111
|
| MeSH ID |
C060343
|
| PubChem ID |
65866
|
| TTD Drug ID |
D0P6ZH
|
| NDC Product Code |
Not Available |
| Synonyms |
lercanidipine | methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | lercanidipine hydrochloride | Zanidip | Lerdip | Lercadip | REC 15-2375 | REC-15-2375 |
|
| Chemical Information |
| Molecular Formula |
C36H41N3O6 |
| CAS Registry Number |
100427-26-7 |
| SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+
](=O)[O-])C(=O)OC |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
